Physician profile
Matthew Mathos
NPI 1285126698
$18,439.13
in general payments reported to CMS, 2019-2025
17 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $245 · 2021: $423 · 2022: $1,040 · 2023: $5,578 · 2024: $10K · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,000 · Grant: $5,000 · Travel and Lodging: $3,244 · Food and Beverage: $2,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,000.00 |
| Grant | $5,000.00 |
| Travel and Lodging | $3,244.24 |
| Food and Beverage | $2,998.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12,170.68 | 2023-2024 | Journey II, Real Intelligence, Or3o Dual Mobility |
| Stryker Corporation | $4,026.89 | 2019-2025 | Mako, Insignia, Triathlon |
| Si-Bone, INC. | $594.40 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $500.89 | 2019-2025 | Persona |
| Depuy Synthes Sales INC. | $263.93 | 2019-2023 | Attune |
| Medacta USA, INC. | $163.55 | 2024 | |
| Integra Lifesciences Corporation | $147.59 | 2022 | |
| Cerapedics INC. | $135.85 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Endo Pharmaceuticals INC. | $123.48 | 2022 | |
| Medical Device Business Services, INC. | $78.00 | 2019-2023 | |
| Heraeus Medical, LLC. | $57.85 | 2020 | |
| Medline Industries Lp | $40.38 | 2025 | |
| Restor3d, INC. | $36.06 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $34.66 | 2025 | |
| Bioventus LLC | $26.78 | 2024 | Exogen Ultrasound Bone Healing System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $23.91 | 2025 | Exparel |
| Checkpoint Surgical, INC | $14.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mathos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.